COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on October 13, 2021)

Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.

Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.

For specific updates concerning China and related business advisory, please click here.

Please refresh the page to get the latest updates.

ASEAN coronavirus updates (Live updates by country)

Brunei

Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.

Brunei reported 193 new cases and three deaths on October 13, bringing the tallies to 9,665 cases and 67 deaths.
Brunei recorded 305 new cases on October 12, taking the total to 9,472 cases amid 64 deaths.
Brunei saw 187 new cases on October 11, bringing the totals to 9,167 cases amid 64 deaths.

Cambodia

Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.

Cambodia reported 272 new cases and 15 deaths on October 13, taking the tallies to 115,607 cases and 2,559 deaths.
Cambodia recorded 267 new cases and 17 deaths on October 12, taking the totals to 115,335 cases and 2,544 deaths.
Cambodia saw 258 new cases and 21 deaths on October 11, bringing the tallies to 115,068 cases and 2,527 deaths.

Indonesia

Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 270 million. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population.

Indonesia saw 1,233 new cases and 48 deaths on October 13, taking the totals to 4,231,046 cases and 142,811 deaths.
Indonesia recorded 1,261 new cases and 47 deaths on October 12, taking the tallies to 4,229,813 cases and 142,763 deaths.
Indonesia reported 620 new cases and 65 deaths on October 11, bringing the totals to 4,228,552 cases and 142,716 deaths.

Laos

Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.

Laos recorded 549 new cases and three deaths on October 12, taking the totals to 29,398 cases and 33 deaths.
Laos saw 309 new cases and four deaths on October 11, bringing the tallies to 28,849 cases and 30 deaths.
Laos reported 508 new cases and two deaths on October 10, taking the total to 28,540 cases and 26 deaths.

Malaysia

Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens.

Malaysia saw 7,276 new cases and 103 deaths on October 12, taking the tallies to 2,353,579 cases and 27,525 deaths.
Malaysia recorded 6,709 new cases and 93 deaths on October 11, bringing the totals to 2,346,303 cases and 27,422 deaths.
Malaysia reported 7,373 new cases and 64 deaths on October 10, taking the tallies to 2,339,594 cases and 27,329 deaths.

Myanmar

Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.

Myanmar saw 1,382 new cases and 26 deaths on October 12, bringing the totals to 481,230 cases and 18,188 deaths.
Myanmar reported 1,197 new cases and 28 deaths on October 11, taking the tallies to 479,848 cases and 18,162 deaths.
Myanmar recorded 1,318 new cases and 30 deaths on October 10, bringing the totals to 478,651 cases and 18,134 deaths.

Philippines

The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees.

The Philippines recorded 7,181 new cases and 173 deaths on October 13, bringing the totals to 2,690,455 cases and 40,069 deaths.
The Philippines reported 8,615 new cases and 236 deaths on October 12, taking the tallies to 2,683,372 cases and 39,896 deaths.
The Philippines saw 8,292 new cases and 36 deaths on October 11, bringing the totals to 2,674,814 cases and 39,660 deaths.

Singapore

Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.

Singapore saw 2,976 new cases and 11 deaths on October 12, bringing the totals to 132,205 cases and 183 deaths.
Singapore reported 2,263 new cases and 10 deaths on October 11, taking the tallies to 129,229 cases and 172 deaths.
Singapore recorded 2,809 new cases and nine deaths on October 10, bringing the totals to 126,966 cases and 162 deaths.

Thailand

Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.

Thailand reported 10,064 new cases and 82 deaths on October 13, taking the tallies to 1,740,428 cases and 17,917 deaths.
Thailand saw 9,445 new cases and 84 deaths on October 12, bringing the totals to 1,730,364 cases and 17,835 deaths.
Thailand recorded 10,035 new cases and 60 deaths on October 11, taking the tallies to 1,720,919 cases and 17,751 deaths.

Vietnam

Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.

Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.

As of October 13, 2021, Vietnam’s Ministry of Health confirmed a total of 849,691 cases of COVID-19. However, 786,095 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 20,869 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Dong Nai, Binh Duong, Tay Ninh, and An Giang among others.
As of October 12, 2021, Vietnam’s Ministry of Health confirmed a total of 846,230 cases of COVID-19. However, 784,748 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 20,763 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Dong Nai, Binh Duong, An Giang, and Dak Lak among others.
As of October 11, 2021, Vietnam’s Ministry of Health confirmed a total of 843,281 cases of COVID-19. However, 782,199 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 20,670 deaths due to the pandemic. The latest community transmission cases have been reported from Ho Chi Minh City, Binh Duong, Dong Nai, An Giang, and Binh Thuan among others.

Other Asian countries and Regions

Afghanistan

Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani from obtaining treatment of either.

As of October 13, Afghanistan has 155,627 cases and 7,234 deaths.
Afghanistan has 155,599 cases and 7,230 deaths as of October 12.
As of October 11, Afghanistan has 155,540 cases and 7,228 deaths.

Bangladesh

Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.

Bangladesh has 1,563,501 cases and 27,713 deaths as of October 12.
Bangladesh has 1,562,958 cases and 27,699 deaths as of October 11.
As of October 10, Bangladesh has 1,562,359 cases and 27,688 deaths.

Bahrain

Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.

As of October 12, Bahrain has 275,803 cases and 1,390 deaths.
Bahrain has 275,734 cases and 1,390 deaths as of October 11.
As of October 10, Bahrain has 275,654 cases and 1,390 deaths.

China

For specific updates concerning China, please click here.

For a complete overview of China’s vaccine availability please go here.

China recorded 22 new cases on October 13, bringing the total to 96,457.
China reported 12 new cases on October 12, taking the total to 96,435.
China saw 25 new cases on October 11, bringing the total to 96,423.

East Timor

East Timor is receiving assistance from the Gavi Institute.

East Timor has 19,690 cases and 119 deaths as of October 13.
As of October 12, East Timor has 19,681 cases and 119 deaths.
East Timor has 19,675 cases and 119 deaths as of October 11.

Hong Kong

Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.

As of October 13, Hong Kong has 12,276 cases and 213 deaths.
Hong Kong has 12,273 cases and 213 deaths as of October 12.
As of October 11, Hong Kong has 12,269 cases and 213 deaths.

India

For a complete overview of India’s vaccine availability please go here.

As of October 12, India has 34,000,500 cases and 451,220 deaths.
India has 33,984,479 cases and 450,991 deaths as of October 11.
Our new India-specific updates can be found here.

Iran

Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.

As of October 13, Iran has 5,742,083 cases and 123,275 deaths.
Iran has 5,729,785 cases and 123,081 deaths as of October 12.
As of October 11, Iran has 5,716,394 cases and 122,868 deaths.

Iraq

Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021.

As of October 12, Iraq has 2,026,349 cases and 22,620 deaths.
Iraq has 2,024,705 cases and 22,591 deaths as of October 11.
Iraq has 2,023,761 cases and 22,563 deaths as of October 10.

Japan

Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021.

As of October 13, Japan has 1,711,935 cases and 17,986 deaths.
Japan has 1,711,391 cases and 17,959 deaths as of October 12.
Japan has 1,710,973 cases and 17,941 deaths as of October 11.

Jordan

Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021.

As of October 12, Jordan has 835,969 cases and 10,827 deaths.
Jordan has 834,778 cases and 10,818 deaths as of October 11.
As of October 10, Jordan has 833,471 cases and 10,811 deaths.

Kazakhstan

Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.

As of October 13, Kazakhstan has 908,847 cases and 11,613 deaths.
Kazakhstan has 907,140 cases and 11,584 deaths as of October 12.
As of October 11, Kazakhstan has 905,641 cases and 11,559 deaths.

Kuwait

All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.

Kuwait has 412,158 cases and 2,455 deaths as of October 12.
Kuwait has 412,121 cases and 2,455 deaths as of October 11.
As of October 10, Kuwait has 412,079 cases and 2,454 deaths.

Kyrgyzstan

Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021.

Kyrgyzstan has 179,492 cases and 2,624 deaths as of October 13.
As of October 12, Kyrgyzstan has 179,429 cases and 2,622 deaths.
Kyrgyzstan has 179,338 cases and 2,620 deaths as of October 11.

Lebanon

Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.

Lebanon has 630,950 cases and 8,394 deaths as of October 12.
Lebanon has 630,382 cases and 8,389 deaths as of October 11.
Lebanon has 630,180 cases and 8,385 deaths as of October 10.

Maldives

The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.

As of October 12, the Maldives has 85,732 cases and 235 deaths.
The Maldives has 85,622 cases and 234 deaths as of October 11.
As of October 10, the Maldives has 85,548 cases and 234 deaths.

Mongolia

Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021.

As of October 13, Mongolia has 330,869 cases and 1,482 deaths.
Mongolia has 328,304 cases and 1,465 deaths as of October 12.
As of October 11, Mongolia has 326,738 cases and 1,450 deaths.

Nepal

Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.

As of October 13, Nepal has 803,878 cases and 11,261 deaths.
Nepal has 803,552 cases and 11,257 deaths as of October 12.
Nepal has 802,861 cases and 11,243 deaths as of October 11.

North Korea

North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.

North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.

Oman

Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).

Oman has 304,013 cases and 4,103 deaths as of October 13.
As of October 12, Oman has 303,999 cases and 4,103 deaths.
As of October 11, Oman has 303,978 cases and 4,102 deaths.

Pakistan

Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021.

Pakistan has 1,260,669 cases and 28,173 deaths as of October 13.
As of October 12, Pakistan has 1,259,648 cases and 28,152 deaths.
Pakistan has 1,258,959 cases and 28,134 deaths as of October 11.

Palestine

Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.

As of October 12, Palestine has 415,182 cases and 4,264 deaths.
Palestine has 414,373 cases and 4,253 deaths as of October 11.
As of October 10, Palestine has 413,410 cases and 4,236 deaths.

Qatar

Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021.

As of October 13, Qatar has 237,662 cases and 607 deaths.
Qatar has 237,579 cases and 607 deaths as of October 12.
Qatar has 237,483 cases and 607 deaths as of October 11.

Russia

A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.

Russia has 7,861,681 cases and 219,329 deaths as of October 13.
As of October 12, Russia has 7,832,964 cases and 218,345 deaths.
Our new Russia-specific updates here.

Saudi Arabia

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021.

Saudi Arabia has 547,761 cases and 8,753 deaths as of October 13.
As of October 12, Saudi Arabia has 547,704 cases and 8,751 deaths.
As of October 11, Saudi Arabia has 547,649 cases and 8,748 deaths.

South Korea

South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021.

South Korea has 335,742 cases and 2,605 deaths as of October 13.
As of October 12, South Korea has 334,163 cases and 2,594 deaths.
South Korea has 332,816 cases and 2,583 deaths as of October 11.

Sri Lanka

Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.

Sri Lanka has 527,735 cases and 13,377 deaths as of October 12.
As of October 11, Sri Lanka has 527,064 cases and 13,354 deaths.
Sri Lanka has 526,383 cases and 13,331 deaths as of October 10.

Taiwan

Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.

Taiwan has 16,313 cases and 846 deaths as of October 13.
As of October 12, Taiwan has 16,309 cases and 846 deaths.
Taiwan has 16,305 cases and 846 deaths as of October 11.

Turkey

Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.

As of October 12, Turkey has 7,508,975 cases and 66,605 deaths.
Turkey has 7,475,115 cases and 66,368 deaths as of October 11.
As of October 10, Turkey has 7,444,552 cases and 66,180 deaths.

United Arab Emirates

The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates. The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.

The UAE has 738,026 cases and 2,115 deaths as of October 12.
The UAE has 737,890 cases and 2,114 deaths as of October 11.
As of October 10, the UAE has 737,766 cases and 2,113 deaths.

Uzbekistan

Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021.

As of October 12, Uzbekistan has 178,986 cases and 1,273 deaths.
Uzbekistan has 178,637 cases and 1,271 deaths as of October 11.
As of October 10, Uzbekistan has 178,259 cases and 1,269 deaths.

Yemen

Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.

Yemen has 9,412 cases and 1,787 deaths as of October 12.
Yemen has 9,402 cases and 1,782 deaths as of October 11.
As of October 10, Yemen has 9,369 cases and 1,778 deaths.